Insulin-like growth factors (IGFs) have been associated with growth, body size, physical activity and colorectal cancer (CRC). We hypothesized that variants in IGF-related genes increase the CRC susceptibility associated with a larger body size and a lack of physical activity. We assessed this in The Netherlands Cohort Study. Participants (n = 120 852) completed a baseline questionnaire on diet and cancer. ~75% returned toenail clippings. Using a case-cohort approach and 16.3 years of follow-up, toenail DNA from 3768 subcohort members and 2580 CRC cases was genotyped. We aggregated unfavorable alleles (potentially increasing CRC risk) for 18 single nucleotide polymorphisms in 8 genes into a sum score. The sum score (in tertiles) and an IGF1 19-CA repeat polymorphism (19/19, 19/non-19 and non-19/non-19 repeats) in combination with body size (mostly in tertiles) and (non-)occupational physical activity (>12, 8-12 and <8 kJ/min in the job and >90, >60-90, >30-60 and ≤30 min/day) were analyzed by Cox regression. Increasingly higher hazard ratios (HRs) for CRC were observed for a larger adult body mass index, larger trouser size and tallness in the presence of more unfavorable alleles in men. HRs (95% confidence intervals) for joint effects were 1.55 (1.06-2.25), 1.78 (1.29-2.46) and 1.48 (1.01-2.17), respectively. In women, variant repeat alleles halved CRC risk irrespective of body size and physical activity. Almost no interactions tested significant. To conclude, a larger body size was a CRC risk factor in men in the presence of an accumulation of unfavorable alleles in IGF-related genes, but interactions were generally nonsignificant.
Introduction
Colorectal cancer (CRC) has emerged as a complex disease as indicated by that risk factors differ in men and women and for cancers occurring in different subsites in the colorectum. Body fatness, tallness and a lack of physical activity are risk factors for CRC (1) . Associations are clearer in men than in women and with respect to the colon as compared with the rectum (1) . This heterogeneity in associations may be due to that different mechanisms are at play in men and women or in relation to different subsites. The study of gene-environment interactions (GxE) will help identify the mechanisms through which body size and physical activity influence CRC risk.
A mechanism of interest in the context of body size, physical activity and CRC is the insulin-like growth factor (IGF) pathway. The IGF pathway is involved in normal growth and putatively tumorigenesis (2) . Key players in the IGF pathway are IGF-1, the main growth factor in adult life and IGF binding proteins, which regulate IGF-1 availability and which can act as tumor suppressors locally (2) . Involvement of the IGF pathway in linking body fatness and physical activity to colorectal tumorigenesis is plausible considering several lines of observational evidence. First of all, obesity has been associated with blood levels of IGF-1 (inverse U-shaped relationship) and IGFBP-1 and -2 (inverse relationship) (3) . Second, higher levels of IGF-1 and lower levels of IGFBPs have been associated with an increased CRC risk (3) . Third, genetic variants in IGF-related genes have been associated with CRC risk . Included here are studies on genetic variants in genes encoding for adiponectin, its receptors and peroxisome proliferator-activated receptor gamma in relation to CRC risk. These adipokines are worth considering because these have been associated with glucose and lipid homeostasis, insulin resistance and compensatory hyperinsulinaemia, and thereby potentially influence IGF-1 levels and CRC risk (25) (26) (27) . Finally, type 2 diabetics have been shown to be at an increased CRC risk, which might be in part explained by hyperinsulinaemia stimulating the production of IGF-1 (28) .
Only few studies have investigated joint effects of genetic variants in IGF-related genes with body size and physical activity on CRC risk. Those that were conducted yielded inconsistent results (23, (29) (30) (31) . Using data from The Netherlands Cohort Study (NLCS), we investigated GxE interactions between body size and physical activity and single nucleotide polymorphisms (SNPs) in IGF-related genes by means of a genetic sum score. The genetic sum score optimized power and allowed for the quantification of sex-and subsite-specific risks. We also studied joint effects of an IGF1 19-CA repeat polymorphism with body size and physical activity, because this polymorphism was associated with CRC risk in the literature, though inconsistently (7, (21) (22) (23) . This study builds on previous studies within the NLCS, which have shown a larger body size, a lack of physical activity (32, 33) and a higher genetic sum score to be CRC risk factors, particularly in men, whereas variant IGF1 19-CA repeat alleles were found to decrease CRC risk in women (manuscript submitted for publication).
Materials and methods

Study population and design
The NLCS includes 120 852 men and women who were between 55 and 69 years old at baseline in 1986, when completing a self-administered questionnaire on diet and cancer. Participants originate from the general population in The Netherlands and were sampled via the municipal population registries. The NLCS has been described in detail previously (34) . The baseline questionnaire included a semi-quantitative 150-item food frequency questionnaire, which was found to rank individuals adequately according to dietary intake when compared with a 9-day dietary record (35) , and was shown a good indicator of intake for at least 5 years (36) . Along with returning the questionnaire, participants were asked to return toenail clippings by way of an enclosed envelope. Approximately 90 000 participants provided toenail clippings. Toenail DNA isolation is performed according to the DNA extraction protocol of Cline et al. (37) . with some adjustments (38) . The NLCS was approved by the review boards of the TNO Nutrition and Food Research Institute (Zeist, The Netherlands) and Maastricht University (Maastricht, The Netherlands).
DNA isolation, the processing of questionnaires and the follow-up are performed using a case-cohort approach. This approach entails that a subcohort (n = 5000), which was randomly selected immediately after baseline, is followed up through linkage to the Central Bureau of Genealogy and municipal registries to estimate the accumulated person-time at risk (~100% completeness). Participants who reported a history of cancer (other than skin cancer) were excluded from follow-up, leaving 4774 subcohort members. The whole cohort is followed up for incident cancer cases through linkage to the population-based cancer registry and PALGA (The Netherlands pathology database) (>96% completeness) (39, 40) . After 16.3 years, there were 3440 incident CRC cases. Toenail clippings were available for 3768 subcohort members (78.9%) and 2580 CRC cases (75.0%), of which 114 CRC cases in the subcohort. The subcohort is representative of the total cohort, and so the 114 subcohort CRC cases were included in both counts, leaving a total of 6234 unique individuals with toenail samples for genotyping.
Variant selection and genotyping
Gene and SNP selection. We selected genes encoding for factors in or regulatory to the IGF pathway and genes encoding for adiponectin, adiponectin receptors and peroxisome proliferator-activated receptor gamma. We searched the literature for SNPs in these genes. We required that SNPs had been significantly associated with a selected endpoint at least twice or with more than 1 selected endpoint (an exception was made for missense variants). Endpoints included CRC risk, relevant traits (i.e. obesity, insulin resistance or blood levels of IGF pathway-related factors), type 2 diabetes mellitus risk and the risk of other obesity-related cancers [cancers of the oesophagus, pancreas, gallbladder, breast (in postmenopausal women), endometrium and kidney (41)]. Our literature-based strategy avoided overfitting of the cumulative model due to potential false-positive findings in a single dataset. A more elaborate description of our SNP selection strategy and prioritization is available in Supplemental Material, available at Carcinogenesis Online. Prioritization was necessary, because the iPLEX™ assay for the SEQUENOM® MassARRAY® platform (Sequenom, Hamburg, Germany) allows high-throughput genotyping of a maximum of 40 SNPs at once. Not all SNPs can be combined due to sequence incompatibilities between the sequences flanking the SNPs. In total, 25 SNPs in 9 genes could be included in the assay.
SNP genotyping. The protocol for genotyping on the SEQUENOM® MassARRAY® platform has been described previously (42) and was carried out using 100 ng of toenail DNA of 6234 subcohort members and CRC cases, pipetted into 384-well plates. Included were duplicate samples for a random selection of 314 samples and 436 water controls. Twenty-four out of the 25 SNPs in the assay were successfully genotyped. Genotyping of SNP rs35767 failed as only the C-allele was found. Four samples were excluded because our laboratory technicians noted a possible contamination. The reproducibility of genotypes was 98.8% or higher for the different SNPs. All SNPs had call rates of 92.6% or higher, except SNP rs4773082, which had a call rate of 83.6%. All SNPs adhered to Hardy Weinberg equilibrium in subcohort members, except SNP rs1342387 (P value = 0.02, Supplementary Table 1, available at Carcinogenesis Online). Since one of these 24 SNPs may be expected to deviate from Hardy Weinberg equilibrium on the basis of chance alone when considering that our study population, although large, is a random sample of the base population, and since all SNPs were genotyped simultaneously, rendering genotyping errors unlikely, we did not exclude this SNP. Exclusion of samples with irreproducible results (n = 1), and samples with a call rate less than 95% (n = 532, 8.5%) resulted in 5697 samples for further analysis.
Genetic sum score. For 18 of the 24 SNPs, the literature was unequivocal as regards to which allele was the unfavorable allele (Supplementary Table 1 , available at Carcinogenesis Online). Alleles were considered 'unfavorable' if associated with CRC endpoints, type 2 diabetes mellitus or other obesity-related cancers in a risk-increasing manner, or if associated with overweight, obesity, insulin resistance or blood levels of IGF pathway-related factors in a manner that may increase CRC risk. Unfavorable alleles were aggregated into a genetic sum score, which was categorized into tertiles as based on the distribution in the subcohort. The rationale for using the genetic sum score was that it integrates information across genes, which is important because there may be functional compensation between genes (43) and gene-gene interactions (44 reverse: 5′-GCTAGCCAGCTGGTGTTATT-3′) were fluorescently labelled with 6-FAM (blue), NED (yellow) and PET (red), which enabled the simultaneous analysis of three samples in a single run on the ABI 3730xl DNA Analyzer. The protocol was carried out in the dark because of the light-sensitivity of the fluorescent labels. The PCR reactions were performed using the following cycles: 94ºC for 10 min, followed by 35 Rosen et al. (45) ., distinguishing between individuals homozygous for the wild-type allele (19/19 CA repeats), heterozygous individuals (19/non-19 CA repeats) and individuals carrying two variant alleles (non-19/non-19 CA repeats). The IGF1 19-CA repeat polymorphism was not in Hardy Weinberg equilibrium in the subcohort when taking into account the multiallelic character of this locus (P value < 0.001). However, it must be noted that deviations may arise due to the presence of rare alleles and genotypes, which is the case in our population. We, therefore, did not exclude this polymorphism from further analysis. We analyzed this variant separately from the genetic sum score for two reasons. Primarily, the IGF1 19-CA repeat polymorphism may be a conceptually different variant than a SNP, meaning the assumption that all variants in the genetic sum score have a similar weight may not hold for this variant in particular. Second, previous studies showed increased (7, 22, 23) and decreased CRC risks (21) for variant repeat alleles, rendering the unfavorable allele unknown. Exclusion of participants with inconsistent/incomplete questionnaires left 2134 subcohort members and 1833 CRC cases in categories of the IGF1 19-CA repeat polymorphism.
Body size
Information derived from the baseline questionnaire indicative of body size included adult body mass index (BMI; weight divided by height squared, kg/m 2 ), trouser/skirt size (Dutch clothing sizes), height (cm) and BMI at age 20. All variables were categorized into sex-specific tertiles as based on the distribution in the subcohort, except trouser/skirt size, which was categorized as <median sex-specific sizes and ≥median sex-specific sizes. Trouser/skirt size correlated well with hip and waist circumferences in a subset of weight-stable NLCS participants and was associated with endometrial and renal cell cancer risk in a fashion as would be expected for waist circumference (46) . When adjusted for BMI, waist circumference is thought to reflect abdominal fatness.
Physical activity
In the NLCS, occupational physical activity in men and non-occupational physical activity in women were indicative of long-term physical activity (this difference exists, because not many women held jobs or only briefly and in the distant past) (33) . Information on occupational physical activity was derived from an individual's self-reported longest held job. The categorization used distinguishes between jobs with an occupational energy expenditure of <8, 8-12 and >12 kJ/min (47) . Non-occupational physical activity in minutes per day was a sum measure of several activities: daily walking/cycling (min/day), weekly recreational walking/cycling, weekly engagement in gardening/doing odd jobs and weekly participation in sports/gymnastics (categories: never, 1, 1-2 and >2 h/week).
Statistical analysis
Sex-and subsite-specific hazard ratios (HRs) and 95% confidence intervals for CRC were estimated using Cox regression for all linear combinations of categories of genetic variants and body size and physical activity. In this study on joint effects, we coded variables such that higher combined categories were expected to increase risk. This entailed that we reversed the coding of the physical activity variables. We refrained from recoding the IGF1 19-CA repeat polymorphism, because the literature was unclear about which allele was risk-increasing.
Each Cox model yielded between 6 and 12 HRs (depending on the number of combined categories). We will highlight three HRs in our description of the results: those indicative of "genetic effects," "effects of body size and physical activity" and "joint effects." "Genetic effects" are indicated by HRs comparing the highest versus lowest tertile of the genetic sum score and hazard rations comparing variant versus wild-type IGF1 19-CA repeat alleles in the presence of a small body size or a high level of physical activity. "Effects of body size or physical activity" are indicated by HRs comparing individuals with a large versus small body size and HRs comparing a low versus high physical activity level in the presence of few unfavorable alleles or the wild-type IGF1 19-CA repeat allele. "Joint effects" are indicated by HRs comparing individuals in highest versus lowest combined categories. These HRs were also used for calculating the relative excess risk due to interaction (RERI). This RERI was derived from the formula RERI = RR 11 -RR 10 -RR 01 + 1 (48) . In this formula, RR 11 , RR 10 and RR 01 correspond to the relative risk (or HR) observed for the joint effect, the genetic effect and the effect of body size or physical activity, as described above. Corresponding 95% bias-corrected confidence intervals were estimated by bootstrapping (n bootstrap samples = 1000) (49) . The RERI is a measure for additive interaction, that is, departure from additivity of effects on a HR scale. In addition, we assessed multiplicative interactions using the Wald test.
To account for the additional variance introduced by sampling the subcohort from the entire cohort, standard errors were estimated using the robust Huber-White sandwich estimator (50) . The proportional hazards assumption was tested using the scaled Schoenfeld residuals and by visually inspecting the -log-log-transformed hazard curves (there were no apparent violations). Models were adjusted for predefined potential confounders [age (years), smoking status (never, ex, current), alcohol intake (0, 0.1-29 ≥30 g/d), total energy intake (kcal/d), processed meat intake (g/d), meat intake (g/d) and first-degree family history of CRC (yes/no)]. In addition, all models, except models for physical activity, were adjusted for physical activity; models for trouser/skirt size and physical activity were adjusted for adult BMI (kg/m 2 ); and models for height were adjusted for weight (kg). To check for the influence of preclinical disease, a sensitivity analysis was conducted in which the first 2 years of follow-up were excluded (with no essential changes in results).
Cox regression analyses were conducted using Stata version 12 (Stata Corp., College Station, TX). Graphical plots were produced using R version 2.15.1 (the R Foundation for Statistical Computing). Statistical significance was indicated by a P value <0.05 for two-sided testing. We did not correct for multiple testing, because our study was hypothesis-based and our use of a genetic sum score significantly reduced the number of tests that had to be performed. Table 1 shows the distribution of subcohort members and CRC cases across categories of the genetic sum score, the IGF1 19-CA repeat polymorphism, adult BMI, trouser/skirt size, height, BMI at age 20, physical activity and potential confounders. Comparison between subcohort members and CRC cases in men and women most clearly showed a difference in the percentage of individuals with a family history of CRC.
Results
Baseline characteristics
The genetic sum score and body size and physical activity
Men. A pattern of increasing CRC risks was observed across combined categories between the genetic sum score and adult BMI, trouser size, height, BMI at age 20 and physical activity in men (Table 2 ). HRs indicative of joint effects reached statistical significance for combinations including adult BMI, trouser size and height. HRs (95% CIs) for CRC comparing the highest with the lowest tertile of the genetic sum score in the presence of a small body size (genetic effects), comparing a large with a small body size in the lowest tertile of the genetic sum score (effects of body size), and comparing highest with lowest combined categories (joint effects) were 1. In addition, a significantly increased HR for CRC comparing the highest with the lowest tertile of the genetic sum score was observed in the presence of a high physical activity level (HR = 1.83, 95% CI: 1.00, 3.35). Other estimated HRs were not significant.
Subsite-specific analyses showed a similar pattern as seen for CRC in relation to colon but not rectal cancer in men (Figure 1 and Supplementary Abbreviations: BMI, body mass index; PY, person-years at risk; RERI, relative excess risk due to interaction; T, tertile. Note on multiplicative interactions: none of the multiplicative interactions tested using the Wald test were statistically significant, except for the interaction between the genetic sum score and BMI in relation to colon cancer risk. The RERI is a measure of additive interaction.
a All models were adjusted for age, smoking status, alcohol intake, processed meat intake, meat intake, total energy intake and first-degree family history of colorectal cancer. In addition, all models, except models for occupational physical activity, were adjusted for occupational physical activity; models for adult trouser size and occupational physical activity were adjusted for BMI; and models for height were adjusted for weight.
Online (Table 3) . Most HRs for CRC were not statistically significant, except for combinations including height and physical activity. HRs (95% CIs) for CRC comparing the highest with the lowest tertile of the genetic sum score in the presence of a small body size or a high physical activity level (genetic effects), comparing a large with a small body size or a high with a low physical activity level in the lowest tertile of the genetic sum score (effects of body size) and comparing highest with lowest combined categories (joint effects) were 1 Subsite-specific analyses in women were generally consistent with overall results (Figure 2 and Supplementary Table 3 , available at Carcinogenesis Online). The HR indicative of a joint effect of the genetic sum score with physical activity was strongly increased in relation to rectal cancer, but the confidence interval was wide (HR = 4.22, 95% CI: 1.70, 10.47) (Panel B of Figure 2 ). This suggests that this HR was unstable, warranting caution when interpreting the joint effect of the genetic sum score with physical activity on CRC, which may be reflecting results for rectal cancer. Figure 3 ). In subsite-specific analyses, this HR was not statistically significant.
Women. We also observed no risk pattern across combined categories of the IGF1 19-CA repeat polymorphism and adult BMI, trouser size, height, BMI at age 20 and physical activity in women (Panel B of Figure 3 and Supplementary Table 5 , available at Carcinogenesis Online). Decreased CRC risks were observed for joint effects of variant repeat alleles with a high BMI and ≥median trouser/skirt size (purple bullets in Panel B of Figure 3 ), but even stronger decreased CRC risks were evident for variant repeat alleles in the presence of a low BMI, <median trouser/ skirt size, short height, low BMI at age 20 and high level of physical activity (blue bullets in Panel B of Figure 3 
GxE interaction tests
Most gene-environment interactions were not statistically significant when tested on an additive scale using the RERIs or when tested on a multiplicative scale (Supplementary Tables  2-5 , available at Carcinogenesis Online). Exceptions were the multiplicative interaction between the genetic sum score and adult BMI in relation to colon cancer risk in men; the multiplicative interaction between the genetic sum score and physical activity in relation to CRC risk in women (P values < 0.05); and the RERI for combinations of the IGF1 19-CA repeat polymorphism with trouser size and BMI at age 20 in relation to rectal cancer in men Abbreviations: BMI, body mass index; PY, person-years at risk; RERI, relative excess risk due to interaction; T, tertile. Note on multiplicative interactions: none of the multiplicative interactions tested using the Wald test were statistically significant, except for the interaction between the genetic sum score and non-occupational physical activity in relation to colorectal cancer risk. The RERI is a measure of additive interaction.
a All models were adjusted for age, smoking status, alcohol intake, meat intake, processed meat intake, total energy intake and first-degree family history of colorectal cancer. In addition, all models, except models for non-occupational physical activity, were adjusted for non-occupational physical activity; models for adult trouser/skirt size and non-occupational physical activity were adjusted for adult BMI; and models for height were adjusted for weight. (RERI = 0.63, 95% CI: 0.03, 1.14 and RERI = 1.05, 95% CI: 0.10, 2.09, respectively).
Discussion
We hypothesized that the IGF pathway is a biological mechanism through which body size and physical activity may influence CRC risk, and therefore assessed joint effects of genetic variants in IGF-related genes with body size and physical activity. To our knowledge, this is the most comprehensive study on this topic. We observed that a larger body size was a risk factor for colon but not rectal cancer in men in the presence of an accumulation of unfavorable alleles in IGF-related genes as indicated by a higher genetic sum score. Risk was significantly increased with 50-110%. We also found halved colon cancer risks in women for variant IGF1 19-CA repeat alleles, but these were irrespective of body size and physical activity. Most interaction tests did not reach significance.
Previous studies showed interactions between physical activity and SNP rs2665802 in GH1 (29) , and between BMI and SNPs rs2289046 in IRS2 (31), rs1063538 in ADIPOQ (30) and rs1539355 in ADIPOR1 (30) . There were no interactions for SNPs rs6214 in IGF1 (31), rs3110697 (31) and rs2854744 (23) in IGFBP3, rs1801278 in IRS1 (23), rs1805097 in IRS2 (23), other tagSNPs in ADIPOQ and ADIPOR1 (30) , or the IGF1 19-CA repeat polymorphism (23) . Interestingly, the observed joint effects in men in our study were present in relation to both proximal and distal colon cancer risk, whereas marginal associations based on NLCS data mainly showed associations between body size and distal colon cancer risk (32) . This perhaps reiterates that CRC has a complex multifactorial etiology as reflected in that it is a heterogeneous disease. On the other hand, it cannot be excluded that the joint effects in relation to proximal colon cancer risk simply reflected main effects of the genetic sum score (manuscript submitted for publication), especially considering the absence of significant tests for interaction.
That joint effects of the genetic sum score with body size in relation to CRC risk at all subsites were less clear in women may be logical considering that female reproductive hormones might counteract the insulin resistance associated with body fatness. This is suggested by experimental findings showing that estrogens improved insulin sensitivity in obesityinduced mice, influencing CRC progression (51) . In addition, the European Prospective Investigation into Cancer observed a positive association between waist/hip ratio and colon cancer risk in postmenopausal women not using hormone replacement therapy (HRT), whereas this association was absent in women using HRT (52) . Possibly, therefore, HRT counteracted the insulin resistance associated with abdominal fatness, nullifying CRC risk in women in the European Prospective Investigation into Cancer. This fits with that HRT in itself has been associated with a reduced CRC risk (53) . Additional adjustment for HRT use in our data did not change results, but only a small percentage of female subcohort members reported HRT use (12.8%).
The general lack of statistically significant additive and multiplicative interactions along with the observation of joint effects of the genetic sum score with body size on colon cancer risk in men is confusing. However, where statistically significant interactions would have strengthened our findings, the absence of these does not argue against a biological interaction (48). This becomes apparent when thinking of the sufficient-component cause model, in which interaction is defined as the participation of two component causes in the same sufficient cause (54) . Another reason for the general lack of statistically significant interactions in this study may have been power. It has been described that a four times larger sample size is needed to detect an interaction effect as compared with a marginal effect of similar magnitude (55) . Thus, in the presence of small interaction effects, the power to detect a statistically significant interaction may have been limited, even in this large study. It is furthermore important to realize that statistical interaction tests require there to be main effects. This lies in the fact that these tests assess whether the observed joint effect differs from the expected joint effect (56) . However, main effects need not be present. In fact, in genetics, true biological epistasis (gene-gene interaction) is described as joint effects of genetic variants that lack an effect on their own (57) . The absence of statistically significant main effects in our study may have hampered the detection of statistically significant interactions. In particular, main effects of body fatness may have been lacking due to our narrow BMI range. BMI distributions were concentrated in the normal range at age 20 (18.5-<25 kg/m 2 ) and in the normal and overweight range in adulthood (18.5-<30 kg/m 2 ). A mere 0.4% of NLCS subcohort members was obese at age 20 (≥30 kg/m 2 ), and 6.5% at an adult age (55-69 years).
The public health relevance of investigating joint effects on CRC risk of genetic variants in IGF-related genes with body size and physical activity is that it will contribute to the evidence base underlying preventive strategies for CRC aimed at maintaining a healthy weight. For this, more research is needed to further elucidate the role of genetic variants in IGF-related genes, but also in genes related to other pathways through which body fatness potentially influences colorectal tumorigenesis, such as the PI3K/Akt/mTOR signalling pathway (58) and inflammatory pathways (59) . On the basis of such studies, genetic subgroups may be discerned which could particularly benefit from targeted CRC prevention strategies.
Strengths of this study include the prospective design of the NLCS and its long follow-up, yielding large case numbers. Strengths also include our SNP selection strategy and the use of a genetic sum score. We only included SNPs that had been associated with selected endpoints in at least two previous studies or SNPs that were missense SNPs, minimizing the chance of selecting SNPs on the basis of false-positive results. Our genetic sum score of unfavorable alleles furthermore integrated information across IGFrelated genes, optimized power and greatly reduced the multiple testing problem. Limitations of this study include the single baseline measurement of body size, physical activity and potential confounders. In addition, numbers did not allow for the assessment of higher-order interactions. For example, we previously reported on an interaction between trouser/skirt size and physical activity in relation to proximal colon cancer risk in women, whereas trouser/skirt size was not marginally associated with CRC endpoints in women (32) . That we could not assess higher-order interactions may be another explanation for the absence of joint effects in women. Furthermore, molecular tumor subtypes, which we did not distinguish due to power limitations, may have hampered the detection of GxE interactions, although major molecular tumor subtypes in CRC, such as microsatellite instability and the CpG island methylator phenotype, correlate with the tumor location (60), for which we performed subanalyses.
To conclude, even though a larger body size was a risk factor for CRC, particularly colon cancer, in men in the presence of an accumulation of unfavorable alleles in IGF-related genes, GxE interactions did not test significant. Variant IGF1 19-CA repeat alleles decreased CRC risk, particularly colon cancer risk, in women irrespective of body size and physical activity.
